1. |
中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2022年版). 传染病信息, 2022, 35(1): 1-26.
|
2. |
四川大学华西医院肝癌MDT团队. 肝细胞肝癌全程多学科规范化管理: 华西医院多学科专家共识(第二版). 中国普外基础与临床杂志, 2020, 27(9): 1062-1077.
|
3. |
阎龙, 戴朝六. 上皮-间质转化与肝细胞癌炎症微环境的关系研究. 中国普外基础与临床杂志, 2017, 24(7): 885-889.
|
4. |
Li Y, Wang WB, Yang L, et al. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy. Nutrition, 2022, 93: 111464. doi: 10.1016/j.nut.2021.111464.
|
5. |
Yang HJ, Guo Z, Yang YT, et al. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis. World J Gastroenterol, 2016, 22(21): 5088-5095.
|
6. |
斯莹, 肖科, 孙长峰, 等. 中性粒细胞与淋巴细胞比值联合系统免疫炎症指数评价乙肝相关肝细胞癌切除术后预后的价值. 中国普外基础与临床杂志, 2021, 28(8): 1056-1061.
|
7. |
Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity, 2019, 51(1): 27-41.
|
8. |
Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis, 2019, 39(1): 26-42.
|
9. |
Wolach O, Sellar RS, Martinod K, et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med, 2018, 10(436): eaan8292.
|
10. |
刘克颜, 宁召臣. 血小板在肿瘤转移中的作用. 中国生物化学与分子生物学报, 2022, 38(8): 1006-1014.
|
11. |
王爱云, 曹玉珠, 韦忠红, 等. 血小板促进肿瘤生长与转移机制研究进展. 中国药理学通报, 2018, 34(8): 1045-1049.
|
12. |
朱明强, 丁佑铭. 肝癌微环境靶向与免疫治疗的研究现状. 临床肝胆病杂志, 2022, 38(8): 1913-1917.
|
13. |
Ethier JL, Desautels D, Templeton A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res, 2017, 19(1): 2.
|
14. |
Liu XB, Gao ZY, Zhang QH, et al. Preoperative neutrophil lymphocyte ratio can be used as a predictor of prognosis in patients with adenocarcinoma of the esophagogastric junction: a systematic review and meta analysis. Front Oncol, 2020, 10: 178.
|
15. |
Mirili C, Guney IB, Paydas S, et al. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Int J Clin Oncol, 2019, 24(2): 168-178.
|
16. |
Johnson PJ, Dhanaraj S, Berhane S, et al. The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Br J Cancer, 2021, 125(5): 714-716.
|
17. |
Schobert IT, Savic LJ, Chapiro J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol, 2020, 30(10): 5663-5673.
|
18. |
Wang D, Bai N, Hu X, et al. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC. PeerJ, 2019, 7: e7132.
|
19. |
Li H, Wang Z, Yang F, et al. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage Ⅰ-Ⅱ adenosquamous carcinoma of the lung. J Surg Oncol, 2020, 121(6): 1027-1035.
|